Tiger, Mikael https://orcid.org/0000-0001-8495-8125
Castelpietra, Giulio https://orcid.org/0000-0002-0309-1345
Wesselhoeft, Rikke
Lundberg, Johan https://orcid.org/0000-0002-4298-3936
Reutfors, Johan https://orcid.org/0000-0003-1372-4262
Article History
Received: 29 September 2023
Revised: 19 March 2024
Accepted: 25 March 2024
First Online: 4 April 2024
Competing interests
: JR reports participation in regulator-mandated research projects funded by pharmaceutical companies, all with funds paid to the institution where he is employed (no personal fees) and with no relation to the work reported in this paper. The remaining authors declare no competing interests.